What is the first-line medication class for treating ADHD in children older than 6 years?

The first-line medication class for treating ADHD in children older than 6 years is psychostimulants. This class of medications works primarily by increasing the levels of certain neurotransmitters in the brain, particularly dopamine and norepinephrine. As a result, they help to improve attention, focus, and impulse control, which are often areas of difficulty for children with ADHD.

Psychostimulants have a strong evidence base supporting their efficacy and are typically the most prescribed medications for ADHD in pediatric populations. Commonly used psychostimulants include methylphenidate and amphetamine-based formulations. These medications are usually well-tolerated, and many children respond positively with an observable reduction in ADHD symptoms.

Other options, such as antidepressants, non-stimulants, and beta blockers, are not typically considered first-line treatments for ADHD. While non-stimulants may be used as alternatives in specific cases, especially when a child has comorbid conditions or does not respond to stimulants, they do not hold the same level of effectiveness in managing ADHD symptoms compared to psychostimulants. Antidepressants and beta blockers do not address the core symptoms of ADHD effectively and are not used for this condition in children.